Literature DB >> 15938130

Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing.

Piero Amodio1, Sami Schiff, Franco Del Piccolo, Daniela Mapelli, Angelo Gatta, Carlo Umiltà.   

Abstract

Attention alterations are reported in cirrhotics. Aiming at clarifying attention functioning in cirrhotics, an inquiry on the functioning of the anterior (AAS) and the posterior (PAS) attention system was performed. Thirty-six cirrhotics without overt hepatic encephalopathy (24 with EEG or TMT-A alterations) and 16 matched control subjects were enrolled. The AAS was studied by the Stroop task measuring selective attention control, the PAS was studied by the Posner task and the Focus task measuring automatic covert orienting and visual focusing of attention respectively. Cirrhotics presented a task-dependent psychomotor slowing (Stroop > Posner > Focus) with an increased percentage of errors in the incongruent condition of the Stroop task [F(1, 57) = 4.9, p < 0.03]. Class C patients had both a selective slowing [F(1, 33) = 4.3, p < 0.05] and an increased percentage of errors in the incongruent condition [F(1, 34) = 5.1, p < 0.05] compared to Class A-B patients and controls. The patients with an altered EEG performed the Stroop test significantly slowly than those without EEG alterations [F(1, 41) = 8.9, p < 0.01] and with a clear trend for a higher number of errors in the incongruent condition [F(1, 39) = 3.8, p < 0.06]. In contrast, attention orienting and focusing were maintained. In conclusion, the AAS is more sensitive than the PAS to the early stages of hepatic encephalopathy.

Entities:  

Mesh:

Year:  2005        PMID: 15938130     DOI: 10.1007/s11011-005-4149-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

Review 1.  The attention system of the human brain.

Authors:  M I Posner; S E Petersen
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

2.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Attention deficits in minimal hepatic encephalopathy.

Authors:  K Weissenborn; S Heidenreich; J Ennen; N Rückert; H Hecker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

4.  Time course analysis of the Stroop phenomenon.

Authors:  M O Glaser; W R Glaser
Journal:  J Exp Psychol Hum Percept Perform       Date:  1982-12       Impact factor: 3.332

5.  Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location.

Authors:  D T Stuss; D Floden; M P Alexander; B Levine; D Katz
Journal:  Neuropsychologia       Date:  2001       Impact factor: 3.139

6.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.

Authors:  P Amodio; F Del Piccolo; P Marchetti; P Angeli; R Iemmolo; L Caregaro; C Merkel; G Gerunda; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors:  H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

9.  Visual attention in cirrhotic patients: a study on covert visual attention orienting.

Authors:  P Amodio; P Marchetti; F Del Piccolo; G Campo; C Rizzo; R M Iemmolo; G Gerunda; L Caregaro; C Merkel; A Gatta
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study.

Authors:  P Elsass; Y Lund; L Ranek
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  23 in total

1.  Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Richard K Sterling; Arun J Sanyal; Muhammad Siddiqui; Scott Matherly; Velimir Luketic; R Todd Stravitz; Michael Fuchs; Leroy R Thacker; HoChong Gilles; Melanie B White; Ariel Unser; James Hovermale; Edith Gavis; Nicole A Noble; James B Wade
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-17       Impact factor: 11.382

2.  Aberrant interhemispheric functional coordination in patients with HBV-related cirrhosis and minimal hepatic encephalopathy.

Authors:  Hua-Jun Chen; Yu Wang; Ming Yang; Xi-Qi Zhu; Gao-Jun Teng
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

Review 3.  Useful tests for hepatic encephalopathy in clinical practice.

Authors:  Eiman Nabi; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2014-01

4.  Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study.

Authors:  Sami Schiff; Antonino Vallesi; Daniela Mapelli; Raffaele Orsato; Andrea Pellegrini; Carlo Umiltà; Angelo Gatta; Piero Amodio
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 5.  Covert Hepatic Encephalopathy: Can My Patient Drive?

Authors:  Jawaid Shaw; Jasmohan S Bajaj
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

Review 6.  Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests).

Authors:  Matthew R Kappus; Jasmohan S Bajaj
Journal:  Clin Liver Dis       Date:  2012-02       Impact factor: 6.126

7.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

8.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

Review 9.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

10.  Modulation of neural activation following treatment of hepatic encephalopathy.

Authors:  Mark J W McPhail; Robert Leech; Vijay P B Grover; Julie A Fitzpatrick; Novraj S Dhanjal; Mary M E Crossey; Henning Pflugrad; Brian K Saxby; Keith Wesnes; M Alex Dresner; Adam D Waldman; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.